Tolebrutinib, an experimental drug, slowed disability progression in advanced MS by 31% in a major trial, offering hope for ...

Food additive mixtures commonly found in diet drinks, soups, dairy desserts and sauces may slightly increase a person's risk ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

An experimental drug may slow the progression of a form of multiple sclerosis that increases disability relentlessly, a new study finds. There are currently no FDA-approved treatments for ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...